Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

Conditions: Sj ögrens Disease; Systemic Lupus Erythematosus; Rheumatoid Arthritis Interventions: Biological: VAY736 1ml PFS; Biological: VAY736 2 ml PFS; Biological: VAY736 2ml AI Sponsors: Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials